SPOP and prostate cancer: Somatic mutation analyses of cancer genomes have indicated that the SPOP gene is always mutated in several human cancers; for example, approximately 10% of prostate cancers [18], 8% of endometrial carcinoma [19] and 2.2% of colorectal cancer [20] reveal SPOP gene mutations.